Targeted Inhibition of Signaling Networks in Pediatric Glioblastoma Stem Cells |
University of California Berkeley / Erin Simonds, PhD |
Young Investigator Grants |
2013 |
California |
Enhancing the Viability, Function, and Safety, of Genetically-Enhanced NK Cells Within the Solid Tumor Microenvironment With IL-15 and a Suicide Gene |
Baylor College of Medicine / Robin Parihar, MD, PhD |
Young Investigator Grants |
2015 |
Texas |
Immune Stimulatory Antigen Loaded Particles (ISAPS) for the Treatment of Solid Childhood Tumors
|
Children’s National Medical Center / Suzanne Miles |
Young Investigator Grants |
2009 |
District of Columbia |
Targeting Aberrant Hh Signaling with BET Bromodomain Inhibition as a Novel Therapeutic Strategy Against MB and DIPG |
Lucile Packard Children’s Hospital at Stanford University School of Medicine / Yujie Tang, PhD |
Young Investigator Grants |
2014 |
California |
Using zebrafish to model the molecular origins of pediatric myeloid malignancies and acute myeloid leukemia |
Dana-Farber Cancer Institute / Evisa Gjini |
Young Investigator Grants |
2011 |
Massachusetts |
Dissecting the Contribution and Inheritance of Germline DNA Damage Repair Gene Mutations in Neuroblastoma |
Dana-Farber Cancer Institute / Riaz Gillani, MD |
Young Investigator Grants |
2021 |
Massachusetts |
Identification of Synthetically Immunogenic Compounds to Synergize with Immunotherapy in Neuroblastoma |
Children’s Hospital of Philadelphia / Adam Wolpaw, MD/PhD |
Young Investigator Grants |
2019 |
Pennsylvania |
A mouse model of Wilms' Tumor
|
Massachusetts General Hospital / Nabeel Bardeesy, PhD |
Young Investigator Grants |
2008 |
Massachusetts |
Investigating the Role of Circadian Rhythm in the Progression of Acute Myeloid Leukemia |
Boston Children’s Hospital / Samantha Morris, PhD |
Young Investigator Grants |
2013 |
Massachusetts |
Development of Targeted DNA-damaging Therapy for ATRX-deficient Pediatric Glioblastoma |
University of Michigan / Carl Koschmann, MD |
Young Investigator Grants |
2014 |
Michigan |